Severe coronavirus disease-2019 (COVID-19) can progress to an acute respiratory distress syndrome (ARDS), which involves alveolar infiltration by activated neutrophils. The beta-blocker metoprolol has been shown to ameliorate exacerbated inflammation in the myocardial infarction setting.

Matéria original


Utility of various inflammatory markers in predicting outcomes of hospitalized patients with COVID-19 pneumonia


Development of Effective Therapeutic Molecule from Natural Sources against Coronavirus Protease